| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2008/06/10 | 03 : 31 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/06/09 | 20 : 00 | Business Wire | Nastech Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/15 | 07 : 55 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/14 | 07 : 13 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/13 | 06 : 28 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/09 | 05 : 05 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Quarterly Report (10-Q) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/09 | 05 : 03 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/09 | 05 : 00 | Business Wire | Nastech Announces First Quarter 2008 Financial Results | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/02 | 05 : 00 | Business Wire | Nastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008 | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/01 | 06 : 19 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/05/01 | 06 : 18 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/04/30 | 02 : 50 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Proxy Statement (definitive) (DEF 14A) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/04/25 | 21 : 00 | Business Wire | Nastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct Offering | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/04/18 | 19 : 04 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/04/03 | 05 : 53 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/04/03 | 05 : 52 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/27 | 21 : 00 | Business Wire | Nastech Pharmaceutical Company Inc. Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/26 | 01 : 41 | Business Wire | Nastech Pharmaceutical Company Inc. to Present RNAi Data | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/22 | 05 : 00 | Business Wire | Nastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/20 | 05 : 47 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/19 | 10 : 36 | Business Wire | Wall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company (NASDAQGM: NSTK) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/18 | 05 : 09 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Annual Report (10-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/18 | 05 : 03 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/18 | 05 : 00 | Business Wire | Nastech Announces Fourth Quarter and Full Year 2007 Financial Results | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/13 | 21 : 00 | Business Wire | Nastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor Forum | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/11 | 21 : 00 | Business Wire | Nastech Pharmaceutical Company Inc. Completes Key RNAi Patent Filings | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/11 | 05 : 17 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/07 | 22 : 00 | Business Wire | Nastech Pharmaceutical Company Inc. Announces Scientific Advisory Board for MDRNA, Inc., its Wholly-Owned RNAi Subsidiary | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/05 | 07 : 27 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 2008/03/01 | 04 : 23 | PR Newswire (US) | Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, Ma | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |